Showing results (61-70 of 5,000) with videos related to
Sort By:
Pageof 500
American Journal of Clinical Oncology|April 25, 2001
Phase 1 drug interaction study of suramin and warfarin in patients with prostate cancerM Meyer, E Jeong, B Bolinger, et al.American Journal of Clinical Oncology|April 25, 2001
Diffuse large B-cell non-Hodgkin's lymphoma presenting as a vaginal mass in a patient with a history of intestinal mucosa-associated lymphoid tissue (MALT) lymphomaC Hosing, R S Freedman, P McLaughlin, et al.American Journal of Clinical Oncology|July 28, 2001
Amiodarone and radiation therapy sequelaeC M Wilkinson, G J Weidner, A C PaulinoAmerican Journal of Clinical Oncology|July 28, 2001
Hypercalcemia mediated by parathyroid hormone-related protein as an early manifestation of pancreatic adenocarcinoma metastasis: a case reportM S Rasnake, C Glanton, D Ornstein, et al.American Journal of Clinical Oncology|February 1, 1992
Non-small-cell lung cancer (NSCLC): chemotherapy in advanced disease. Our experience in ten yearsM Gonzalez Baron, C Garcia Giron, P Zamora, et al.American Journal of Clinical Oncology|April 1, 1992
Phase II trial of combination chemotherapy and irradiation in non-small-cell lung cancer, Radiation Therapy Oncology Group 88-04W T Sause, C Scott, S Taylor, et al.American Journal of Clinical Oncology|August 1, 1992
Phase II study of cisplatin continuous infusion plus vindesine in the treatment of non-small-cell lung cancerK Mori, Y Saito, K TominagaAmerican Journal of Clinical Oncology|April 26, 2003
Irinotecan in the treatment of advanced colorectal cancer in patients pretreated with Fluorouracil-based chemotherapy: a study to determine recommendable therapeutic dosageJose M Viéitez, Juan Carrasco, Emilio Esteban, et al.American Journal of Clinical Oncology|April 26, 2003
Phase I trial of carboplatin and paclitaxel with escalating doses of oral topotecan in patients with solid tumorsNasser Hanna, Chris Sweeney, Karen Fife, et al.American Journal of Clinical Oncology|August 7, 2003
Cyclooxygenase-2 (COX-2) enzyme inhibitors and radiotherapy: preclinical basisLuka MilasPageof 500